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for group 2 (p<O.0001), and was -30.1±14.6% for group 2a and -21.3±10.9% for group 
2b (p<O.O001). The Delta-RR2 was +3.6±12.6% for group I and -4.0±14.6% for group 2 
(p<O.O01), and was -5.8±12.3% for group 2a and +0.3±17.6% for group 2b (p=0.O01). 
CONCLUSION: Majority of VTNF episodes occurred in forms of storms. Episodes during 
storms were associated with greater changes in R-R intervals compared to discrete epi- 
sodes. This raises the possibility of using changes in R-R intervals as an indicator to 
determine patients' propensity to experience VT/VF storms. 
1067-108 Is One Successful VF Conversion Adequate for Sate ICD 
Implantation? 
Michael R. Gold. Stephen R. Shorofsky, Eric J. Rashba, University of Maryiand, 
Baltimore, Maryland. 
Background: Multiple successful conversions of ventricular fibrillation (VF) have been 
recommended as the minimum criteria for safe defibrillator (ICD) implantation, because 
of the statistical probability of success curve for defibrillation, We postulated that a single 
success at a low energy (14 J) would provide an adequate safety margin for devices pro- 
grammed to maximum energy (31 J). 
Methods: The Low Energy Safety Study (LESS) enrolled 720 patients at 32 centers 
undergoing initial ICD implantation with a dual coil transvenous lead and active pulse 
generator (triad configuration). At implant the defibrillation threshold (DFT) was deter- 
mined using a rigorous protocol beginning at 14 J that required at least 4 shocks to deter- 
mine the DFT++. Half of all patients were then randomized to chronic programming with 
all shocks at maximum energy and the conversion rates for spontaneous VF (ventricular 
arrhythmias with rates > 200 bpm) were evaluated, 
Results: In LESS, 318 patients were randomized to all shocks at 31 J, including 254 with 
success on their initial attempt at 14 J. During a mean follow-up duration of 24+12 
months, the full cohort experienced 112 spontaneous episodes of VF, of which 103 (92%) 
were successfully converted with the first shock and 109 (97.3%) were successfully con- 
varied with the first 2 shocks. In the subset with the 14 J initial attempt success, 66 spon- 
taneous VF episodes Occurred, of which 59 (89,4%) were successfully converted with 
the first shock and 64 (97%) were successfully converted with the first 2 shocks. The 
device eventually converted all episodes in both groups. 
Conclusions: An implant criterion of one success at 14J appears adequate and 
deserves further study. 
1067-109 Cl inical  Features and Causes of Coaxial Polyurethane 
ICD Lead Failure 
Norman Ratliff, Robed G. Hauser, G. Frank O. Tyers, David L. Hayes, Andrew E. 
Epstein, Stephen C. Vlay, John Hayes, Seymour Furman, Jay Gross, Victor Parsonnet, 
David Cannom, Muiticenter Regist~ Minneapolis, Minnesota, Minneapolis Heart 
institute Foundation, Minneapolis, Minnesota. 
Background: The failure of an ICD lead may prevent the detection or termination of VT/ 
VF, or the treatment of a bradyarrhythmia. Coaxial polyurethane ICD leads (ICD-L), 
Transvene RV models 6936/6966 (Medtronic, Inc.) were introduced in 1991. According to 
the manufacturer, 24, 625 U.S. implants have been registered, and an estimated 14,400 
remain active. Recent reports suggest that these ICD-L may be prone to failure. Meth- 
ods: We searched the Multicenter Registry and FDA's MAUDE (Manufacturer and User 
Facility Device Experience) databases for ICD-L device failures. Lead complications due 
to infection, displacement, and iatregenic causes were excluded. As of September 2001, 
the Registry had received 22 reports from 8 NoAh American centers, and MAUDE con- 
tained 438 reports, including 79% from the manufacturer and 21% from user facilities. 
Results: The mean time to failure for these 460 leads was 3.3+/-2.0 years (range:<1 
month-8 years). The primary signs of failure were available for 299 events: inappropriate 
shocks or antitachycardia therapy-39% (118/299), oversensing-15% (46/299), under- 
sensing-7% (20/299), failure to defibrillate-3% (8/299), non-capture or high threshold- 
15% (45/299), impedance change-15% (46/299), and other-5% (16/299). Major clinical 
events included 10 deaths and 17 life-threatening emergencies. Specific causes of fail- 
ure were reported for 267 ICD-L: conductor fracture-68% (181/267), disrupted insulation- 
31% (84/267), and fixation mechanism-1% (2/267); clavicular crush was noted in 6% (16/ 
267). Analyses of 110 ICD-L that were removed and returned to the manufacturer 
revealed that fracture often involved the high voltage coil (37/72) or multiple conductors 
(17/72) and the 80A polyurethane middle (18/38) or outer (17/38) insulation. Conclu- 
sion: ICD-L appear to fail for reasons related to the coaxial design, 80A polyurethane 
insulation, and implant technique. Because of the potentially serious clinical conse- 
quences of ICD-L failure, studies are needed to determine the likelihood of failure, and to 
guide the safe management of patients who have these models. 
1067-110 Ventricular Arrhythmia Recurrence After Quiescent 
Periods in Patients With Impiantable Cardioverter- 
Defibrillators 
Alan X. Zhu, Cengiz Ermis, David G. Benditt, Scott Sakaguchi, Cardiac Arrhythmia 
Center University of Minnesota Cardiovascular Division, Minneapolis. 
Background: Current AHNNASPE recommendations suggest a 6-month symptomatic 
arrhythmia event free interval following placement of an implantable cardioverter defibril- 
lator (ICD) before resumption of driving. An additional 6-month observation period is 
advised if arrhythmia recurs, tn this study, we postulated that the quiescent time to recur- 
rence of arrhythmia may be useful to predict risk of future arhythmia recurrences in ICD 
patients (pts). 
Methods: Data from 254 consecutive ICD pts was reviewed. The interval after ICD 
implant to each ventricular tachycardia(VT)/venthcular fib illation(VF) episode treated by 
ICD pacing or shock was identified. Pts (mean age 64+14.1 years) were followed at 3 to 
6 month intervals for an average of 24_+14.6 months. Mean left ventricle ejection fraction 
(LVEF) was 35_+14.5%. 
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Results: Indication for ICD implant was spontaneous ustained VT (52%) or VF (35%), or 
inducible sustained V'I" (13%). One hundred forty (55%) pts experienced at least one ICD 
treated ventricular arrhythmia. A total of 1920 episodes were treated, VF accounting for 
285 (15%). Amiodarone and ~ blockers, including sotalol were used in 30% and 58% o1 
pts at discharge, and 32% and 58% at the end of follow up penod, respectively. The 
recurrence rates for tCD treated VT/VF during a 6 month period following quiescence 
periods of 3, 6, 9 and 12 months immediately post implant were 24%, 21%, 19% and 
17%, respectively. Conversely, a 6-month quiescent period starting after a treated 
arrhythmia was associated with 45% recurrence risk (p=0.001 vs risk with a 'no arrhyth- 
mia' 6 month period). Logistic regression identified that a low LVEF (<30%) was the only 
significant predictor of arrhythmia recurrence (p=0.02). 
Conclusion: Subsequent VT/VF recurrence risk in ICD pts decreases inversely with the 
length of arrhythmia free period. Fudher, for comparable followup periods, a quiescent 
period immediateJy after implant is associated with a lower recurrence risk than is a simi- 
lar length quiescent period after a treated arrhythmia. However, even long quiescent peri- 
ods are ultimately associated with worrisome VT/VF recurrence. This finding requires 
consideration when providing driving advice for ICD pts. 
1067-111 The Relation of Capacitor Charge Time and Output 
Energy to Battery Voltage Compared in Multiple 
Implantable Cardioverter Defibrillator Pulse Generators 
Claudia Williams, Thomas A. Maffioni, Lee Strickland, Marwan Bahu, Arizona Heart 
Institute, Phoenix, Arizona. 
Background: Comparative data is lacking on implantable cardioveder-defibrillator (ICD) 
systems on the effect of battery voltage on capacitor charge time and output energy. 
Methods: ICD pulse generators were attached to a rhythm simulator and allowed to pace 
and shock into fixed loads. Each ICD was programmed to deliver shocks at 4 energy lev- 
els with 5 episodes for each level (20 episodes/day). Battery voltage was measured at 
the beginning of every sequence and charge time was recorded immediately after each 
shock. The shock output was measured at each energy level by oscilloscope and deliv- 
ered energies calculated. Delivered energy was then compared to programmed outputs 
as well as battery voltage. This was continued until battery depletion. The ICDs tested 
were: Gem DR , Gem III DR (Medtronic), Photon (St. Jude) and Prizm DR, Prizm II DR 
(Guidant). 
Results: A family of graphs was generated showing the relationship of battery voltage to 
charge time at various energy levels (example). ICDs which program delivered energy 
had an error in measured energy as high as 10%, independent of battery voltage. 
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Conclusions: An inverse relationship of battery voltage to capacitor charge time was 
found with differences in charge time between devices remaining constant. Discrepancy 
between programmed delivered energy and measured energy was highest in devices 
with shorter charge times and programmable delivered energy. Measured shock output 
energies were stable throughout the life of all devices. 
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1068-112 Postural Response of Low Frequency Component of 
Heart Rate Variability Is an Increased Risk for Mortality 
in Patients With Coronary Artery Disease 
Jun-ichiro Hayano, Seiji Mukai, Seiichiro Sakata, Hidekatsu Fukuta, ShinU Ishihara, 
Genjiro Kimura, Third Department of Internal Medicine, Nagoya City University Medical 
School, Nagoya, Japan. 
Background: Analysis of heart rate variability (HRV) during head-up tilt testing (HUT) is 
widely used as a cardiac autonomic function test, but its prognostic value in coronary 
artery disease (CAD) is unknown. We examined if autonomic functions assessed by HRV 
during a standardized HUT predicts nsk for death in patients with stable CAD. 
Methods: In a cohort of 250 patients with CAD undergoing elective coronary angiogra- 
phy, we analyzed HRV during standardized HUT under paced breathing with discontinu- 
ing all medications. The patients were subsequently followed up for 99 months and the 
prognostic value of HRV were examined. 
Results: During the followed-up, there were 25 deaths (10%);13 from cardiac causes 
and 12 from non-cardiac causes. Cox regression analysis adjusted for cardiovascular 
risks revealed that increased postural change (upright minus supine) in low-frequency 
power (LF) predicted an increased risk for cardiac death (RR [95% CI] per l-In[ms 2] 
increment, 4.36 [1.64-11.6]), while neither high-frequency component nor its response to 
HUT predicted any form of death. When the patients were tdchotomized by the level of 
postural LF change (large drop< 0.6 In[ms2], small drop and rise>0 In[ms2]), the 3 groups 
did not differ in clinical features or CAD severity at baseline or coronary interventions dur- 
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ing the follow-up period; however, 8-yeer cardiac mortality rates were 0%, 6% and 12%, 
respectively (log-rank test p = 0.008). Additionally, the difference was enhanced when 
analyzed with excluding 64 patients treated with a B-blocker during the follow-up period 
(0%, 7%, 15%, respectively; log-rank test, p = 0,006), 
Conclualone: Posturel response of HRV predicts risk for death in patients with CAD; 
particulady, postural LF increase (LF dse) is an independent risk for cardiac death. 
1068-113 Abnormal  Spat ia l  D ispers ion  o f  QRS Duration Predicts 
Morta l i ty  in Pat ients  With Mi ld to Moderate  Chronic 
Heart  Fa i lure 
Takahisa Yamada, Masatake Fukunami, Tsuyoshi Shimonagata, Kazuaki Kumagai, Akio 
Hirata, Mitsutoshi Asai, Nobuhiko Makino, Hidetaka Kioka, Nodtake Hoki, Osaka 
Prefectural Genera/Hospital, Osaka, Japan. 
Background: The possible predictive value of spatial dispersion of QRS duration (S- 
QRSd) is unknown in patients with chronic heart failure (CHF). The aim of this study is to 
prospectively evaluate the prognostic significance of S-QRSd in patients with mild to 
moderate CHF, using the signal-averaged ECG, 
Methods and Results: We studied 114 consecutive stable outpatients with radionuclide 
left ventdcular ejection fraction < 40% (30-3:7%, NYHA: 2.0-+0.6, ischemic odgin: 64%) 
and 31 age and sex-matched normal controls. Signal-averaged ECG was recorded from 
standard 12 leads and 10 extra-precordial leads (two intercostal spaces upper and lower 
V1, V2 and V4-6). S-QRSd was defined as the difference between the maximum and 
minimum of filtered QRS duration in all of the leads. S-QRSd was significantly greater in 
CHF patients than controls (25.1:t:9.6 vs 15.9_+4,6 ms, p<0.0001). Forty-three (Group I) of 
114 CHF patients had abnormal S-QRSd (>25ms: mean+2SD of controls), while the 
remaining 71 patients (Group II) had not. There were no significant differences in clinical, 
hemodynamic, echocardiographic, biochemical parameters at the entry between Groups 
I and II. During the follow-up period of 47_+18 months, 14 patients had cardiac death (sud- 
den death in 9 and heart failure death in 5). Kaplan-Meier analysis revealed that the car- 
diac and sudden deaths were significantly more often observed in Group I than Group II 
(cardiac death: 28% vs 3%, p<0.0001, sudden death: 19% vs 2%, p<0,001 ). Relative risk 
for cardiac and sudden death in abnormal S-QRSd were 9.9 (95%CI 2.3 to 42.2) and 
13.2 (95%CI 1.7 to 102), respectively. At multivadata Cox analysis, out of the variables 
including clinical, hemodynamic, echocardiographic, biochemical parameters, S-QRSd 
was the only predictor of the cardiac death (p<0.0001, hazard ratio 1.15 [95%CI 1.08 to 
1.23]) and sudden death (p<0.0001, hazard ratio 1,14 [95%CI 1.07 to 1.22]). 
Conclusion: Spatial dispersion of QRS duration in signal-averaged ECG is a powerful 
prognostic marker of the mortality in patients with mild to moderate CHF. 
1066-114 QRS Duration on the Surface12 Lead ECG is an 
Independent Predictor of  Morta l i ty :  A S tudy  o f  4,033 
Pat ients  With Known or  Suspected Coronary Artery  
Disease 
Abdou Elhendv, Stephen C, Hammill, Douglas Mahoney, Kelli Burger, Patdcia A, 
Pellikka, Mayo Clinic, Rochester, Minnesota. 
Rationale. Aim of this study was to assess the relation between QRS duration on the 
ECG and mortality in patients (pts) with known or suspected coronary artery disease 
(CAD). 
Methods. We studied 4033 pts (age 62 _+ 12 years, 2360 men) with known or suspected 
CAD (16% had previous myocardial infarction) who underwent symptom limited exercise 
echocardiography. QRS duration was automatically measured from the surface 12 lead 
ECG. An abnormal exercise echocardiogram was defined as resting or exercise-induced 
wall motion abnormalities. 
Results: There were 252 deaths during a median follow up of 3 years. QRS duration was 
associated with an increased dsk of death (RR = 8.5, CI 4.4 -16.4, p <0.0001). Survival 
curves of pts according to quartiles of QRS duration are shown in graph. In an incremen- 
tal multivariate analysis of clinical, exercise, and echocardiographic data, independent 
predictors of mortality were age, gender, a history of previous infarction, diabetes mellitus 
(Chi 2 = 122), workload (Chi 2 = 193), and exercise wall motion score index (Chi 2 = 211). 
QRS duration was associated with an incremental risk when added to the clinical model 
(Chi 2 =133, p=0.009), exercise ECG model (Chi2= 203, p=0.002) and echocerdiographic 
model (Chi 2 = 216, p=0.03). 
Conclusion. In pts with known or suspected CAD, a prolonged QRS duration is associ- 
ated with an increased risk of death. This risk is persistent after adjustment o clinical risk 
factors, exercise capacity, resting left ventdcular function and myocardial ischemia. 
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1068-115 QRS Duration is a Strong Predictor of Mortality in 
Patients Undergoing Electrophysiologic Studios 
Vi!av Nambi. Vidyasagar Kalahasti, David O. Martin, Cathy Lam, David Yamada, Bruce 
L. Wilkoff, Mark J. Niebauer, Andrea Natale, Walid Saliba, RoPed Schweikert, Frodrick 
Jaeger, Patrick Tchou, Mina K. Chung, The Cleveland Clinic Foundation, Cleveland, 
Ohio. 
Background: Prolonged QRS duration in heart failure patients has been targeted for 
intervention with biventdcular pacing, but whether QRS duration impacts mortality is not 
well studied. We tested the hypothesis that prolonged QRS duration independently pre- 
dicts mortality in patients undergoing electrephysiologic study (EPS). 
Methods: 975 patients without pacemakers undergoing EPS for risk stratification were 
studied. Mortality data were obtained from the Social Security Death Index. The relation 
between QRS duration and mortality was assessed using Cox regression. 
Results: The mean age of subjects was 62.7 years, 709 (76%) were male, mean left ven- 
tricular ejection fraction (EF) was 35.6%, 619 (66%) had coronary artery disease (CAD), 
and 238 (25%) had inducible sustained monomorphic ventdcular tachycsrdia (SMVT). 
Mean QRS duration was 120.4 msec. During a median follow-up of 34.6 months, 174 
patients (19%) died. In univariate analysis, a QRS duration of 120 msec or greater was 
associated with a 2.9 fold increase in mortality (P < 0,001 ). Multivariable analysis showed 
prolonged QRS duration to be the strongest predictor of mortality (hazard ratio=2.1, 
P<0.001) after adjusting for age, EF, CAD, SMVT inducibility, beta-blocker therapy, and 
subsequent defibrillator implantation (figure). 
Conclusion: Patients with prolonged QRS duration are at high risk for mortality. Whether 
shortsning of QRS duration by biventricular pacing will reduce mortality in this high risk 
group merits investigation. 
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1068-116 Temporal Complexity of Repolarization and Mortality In 
Patients With Implantable Cardloverter-Defibrillator8 
Juha S. Perkiomaki. Jean-Philippe Couderc, James P. Daubed, Wojciech Zareba, 
UNiversity of Rochester School of Medicine and Dentist~ Rochester, New York. 
Background: Increased repolarization variability has been attributed to vadous cardiac 
conditions. However, data on its value in predicting adverse outcomes in high risk 
patients are scanty. 
Methods: Forty-six patients with decreased left ventdcular function and implantable car- 
dioverter-defibrillators (ICD) had a high-resolution 10-minuta ECG recordings. The 
patients were followed-up for 772 ± 278 days (mean ± SD) on average. The interval from 
the R-spike to the T-wave peak with maximum amplitude (RTmax) was determined auto- 
matically on beat-to-beat basis after deletion of cycles with premature depoladzations. 
Outliers were edited manually. Temporal beat-to-beat RTmax vadability was analyzed 
using approximate entropy (ApEn) and the short-tarm scaling exponent (A1). 
Results: Eight (17%) patients died during follow-up. The temporal beet-to-peat repolar- 
ization variability and heart rate variability parameters in patients who remained alive and 
who died are shown in Table. When RTmax-ApEn was tested together with the RR inter- 
val, RR-A1, and RR-ApEn in the Cox regression analysis, it still independently predicted 
mortality; hazard ratio = 3.42 (1.21-9.64, 95% CI, p=0.02) for every 0.10 increase in 
RTmax-ApEn. 
Conclusion: Increased temporal complexity of repotarization (RTmax-ApEn) indepen- 
dently predicts mortality in ICD patients. Different nonlinear dynamics of ropolarization 
and heart rate contribute to increased risk of mortality in ICD patients. 
Alive Dead p-value 
RTmax-ApEn 1.00 ± 0.21 1.26 ± 0.13 0,002 
RTmax-A1 0.62 ± 0.07 0.63 ± 0.09 0.57 
RTmax, ms 295 ± 44 275 ± 34 0.28 
RR-ApEn 0.94 ± 0.31 0.92 ± 0.28 0.90 
RR-A1 0.96 ± 0.29 0.63 ± 0.23 0.003 
RR, ms 989 ± 198 872 ± 213 0.13 
1068-117 Prognostic Value of Nonlinear Measures of Heart Rate 
Dynamics in Chronic Hemodlalysis Patients With 
Coronary Artery  Disease 
Hidekatsu Fukuta. Jun-ichiro Hayeno, Shinji Ishihara, Seiichiro Sakata, Hiroshi 
Takahashi, Masaki Yokoya, Takanobu Toriyama, Hirohisa Kawahara, Genjiro Kimura, 
Third Department of Internal Medicine, Nagoya City University Medical School, Nagoya, 
Japan, Department of Hemodia/ysis Treatment, Nagoya Kyoritau Hospital, Nagoya, 
Japan. 
Background: Altered nonlinear dynamics of heart rate are independent predictors of 
death in patients with coronary artery disease (CAD); but, the prognostic value in chronic 
hemodialysis patients with CAD is unknown. 
Methods: In 81 chronic hemodialysis patients undergoing elective coronary angiography 
